The importance of ultrasonographic measurement of peritoneal wall thickness in pediatric chronic peritoneal dialysis patients

References

• Davies SJ, Phillips L, Griffiths AM, Russell RH, Naish PF, Russell GI. What really happens to people on long-term peritoneal dialysis? Kidney Int. 1998;54:2207–2217
   PubMed Web of Science ®Google Scholar
• Williams JD, Craig KJ, Topley N, et al. Morphologic changes in the peritoneal membrane of patients with renal failure. J Am Soc Nephrol. 2002;13:470–479
   PubMed Web of Science ®Google Scholar
• Hung KY, Huang JW, Tsai TJ, Hsieh BS. Peritoneal fibrosing syndrome: Pathogenetic mechanism and current therapeutic strategies. J Chin Med Assoc. 2005;68:401–405
   PubMedGoogle Scholar
• Hung KY, Lin TJ, Tsai TJ, Chen WY. Impact of peritoneal membrane transport on technique failure and patient survival in a population on automated peritoneal dialysis. ASAIO J. 1999;45:568–573
   PubMed Web of Science ®Google Scholar
• Hung KY, Shyu RS, Fang CC, Lee PH, Tsai TJ, Hsieh BS. Dipyridamole inhibits human peritoneal mesothelial cell proliferation in vitro and attenuates rat peritoneal fibrosis in vivo. Kidney Int. 2001;59:2316–2324
   PubMedGoogle Scholar
• Hung KY, Shyu RS, Huang JW, Tsai TJ, Chen WY. Natural changes in peritoneal equilibrium test results in CAPD patients: A retrospective, seven-year cohort survey. Artif Organs. 2000;24:261–264
   PubMed Web of Science ®Google Scholar
• Stoenoiu MS, De Vrises AS, Brouet A, et al. Experimental diabetes induces functional and structural changes in the peritoneum. Kidney Int. 2002;62:668–678
   PubMedGoogle Scholar
• Williams JD, Craig KJ, Topley N, Williams GT. Peritoneal dialysis: Changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int. 2003;63:S158–S161
   Google Scholar
• Margetts PJ, Gyorffy S, Kolb M, et al. Antiangiogenic and antifibrotic gene therapy in chronic infusion model of peritoneal dialysis in rats. J Am Soc Nephrol. 2002;13:721–732
   PubMed Web of Science ®Google Scholar
• Honda K, Hamada C, Nakayama M, et al; Peritoneal Biopsy Study Group of the Japanese Society for Peritoneal Dialysis. Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: A quantitative study of peritoneal membrane morphology. Clin J Am Soc Nephrol. 2008;3:720–728
   PubMedGoogle Scholar
• Ebinc FA, Derici U, Gonen S, et al. TGF-beta-1 gene polymorphisms and peritoneal equilibration test results in CAPD patients. Ren Fail. 2008;30:15–19
   PubMed Web of Science ®Google Scholar
• Twardowski ZJ. Pathophysiology of peritoneal transport. Contrib Nephrol. 2006;150:13–19
   PubMedGoogle Scholar
• Twardowski ZJ. Clinical value of standardized equilibration tests in CAPD patients. Blood Purif. 1989;7:95–108
   PubMed Web of Science ®Google Scholar
• Rodby RA, Firanek CA, Sarpolis AL. Re-evaluation of solute transport groups using the peritoneal equilibration test. Perit Dial Int. 1999;19:438–441
   PubMedGoogle Scholar
• Lee TC, Yang JY, Wang HP, Tsai TJ, Yang Y. Peritoneal thickening is not inevitable in long-term peritoneal dialysis and is associated with peritoneal transport characteristics: A two-centre sonographic study. Nephrol Dial Transplant. 2008;23:1005–1010
   PubMedGoogle Scholar
• Faller U, Stegen P, Klaus G, Mehls O, Tröger J. Sonographic determination of the thickness of the peritoneum in healthy children and paediatric patients on CAPD. Nephrol Dial Transplant. 1998;13:3172–3177
   PubMedGoogle Scholar
• Duman S, Ozbek SS, Gunay ES, et al. What does peritoneal thickness in peritoneal dialysis patients tell us? Adv Perit Dial. 2007;23:28–33
   PubMedGoogle Scholar
• Temiz G, Sahin G, Mukerrem G, et al. Ultrasonographic evaluation of peritoneal membrane thickness and comparison with the effectiveness and duration of CAPD. Int Urol Nephrol. 2013;45:1761–1766
   PubMedGoogle Scholar
• Caltik A, Akyüz SG, Bülbül M, et al. Can sonographic peritoneal thickness be used to follow pediatric patients on peritoneal dialysis? Pediatr Nephrol. 2013;28:811–817
   PubMedGoogle Scholar
• Coles GA, Williams JD, Topley N. Peritoneal inflammation and long-term changes in peritoneal structure and function. In: Gokal R, Khanna R, Krediet RT, Nolph KD, eds. Textbook of Peritoneal Dialysis. 2nd ed. Dordrecht: Kluwer Academic Publishers; 2000:566–583
   Google Scholar
• Plum J, Hermann S, Fusshöller A, et al. Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties. Kidney Int. 2001;78:S42–S47
   Google Scholar
• Margetts PJ, Bonniaud P. Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int. 2003;23:530–541
   PubMed Web of Science ®Google Scholar
• Davies SJ, Bryan J, Phillips L, Russell GI. Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant. 1996;11:498–506
   PubMed Web of Science ®Google Scholar
• Flessner MF, Choi J, Vanpelt H, et al. Correlating structure with solute and water transport in a chronic model of peritoneal inflammation. Am J Renal Physiol. 2006;290:232–240
   Google Scholar
• Twardowski ZJ, Nolph KD, Khanna R, et al. Peritoneal equilibration test. Perit Dial Bull. 1987;7:138–147
   Web of Science ®Google Scholar
• National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for 2006 Updates: Hemodialysis adequacy, peritoneal dialysis adequacy and vascular access. Am J Kidney Dis. 2006;48:S1–S322
   PubMed Web of Science ®Google Scholar
• Topley N, Liberek T, Davenport A, Li FK, Fear H, Williams JD. Activation of inflammation and leukocyte recruitment into the peritoneal cavity. Kidney Int. 1996;56:S17–S21
   Google Scholar
• Mlambo NC, Hylander B, Brauner A. Increased levels of transforming growth factor beta 1 and basic fibroblast growth factor in patients on CAPD: A study during non-infected steady state and peritonitis. Inflammation. 1999;23:131–139
   PubMedGoogle Scholar